Consider Stopping Overactive Bladder Meds During Hospitalization

You'll hear controversy surrounding overactive bladder meds and fall risk.

Many hospitals use immediate-release oral antimuscarinics, such as oxybutynin (Ditropan, etc) or tolterodine (Detrol, etc), as therapeutic interchanges when patients are taking overactive bladder meds at home. It's hoped that fewer trips to the bathroom will lead to fewer falls.

But help put the efficacy and safety of overactive bladder meds into perspective. For example, these meds decrease bathroom trips in women from about 11 per day to 9 or 10.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals